In silico methods have become crucial for the rapid preliminary assessment of drug compound absorption, distribution,… The post ADMET Prediction: Remdesivir & Favipiravir Metabolism appeared first on Archynetys. Source link
The COVID-19 pandemic brought a surge of research into potential treatments and for many, especially those with older loved ones, remdesivir emerged as a frequently discussed option. However, as with… The post Remdesivir & COVID-19: Does Frailty Affect Treatment Outcomes in Seniors? appeared first on News Directory 3. Source link
Enteroviruses are a group of viruses that cause everything from the common cold to meningitis, polio, type 1 diabetes, and much more. Over 100 different types have been described by researchers, and millions of people are infected each year. “Enteroviruses pose a significant global health problem,” said Erlend Ravlo, a PhD research fellow at the … Read more
New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise Table of Contents New hope for COVID-19 Treatment: Novel Antiviral Compound Shows Promise The Quest for Innovative SARS-cov-2… The post Quinoline Antiviral: Promising SARS-CoV-2 Treatment appeared first on NewsyList. Source link
Remdesivir and COVID-19: An Ongoing Inquiry into Efficacy and Personalized Treatment Interviewer: Senior Editor, World-Today-News.com Interviewer: In a world where COVID-19 treatments have been widely debated, what do you find most surprising about the effectiveness of remdesivir? Could the variability in results lead to a paradigm shift in how we approach treatment strategies? Expert: One … Read more
We analysed the clinical presentation of COVID-19 during the 2023–2024 JN-1-related surge in admissions to the ID Unit of a large hospital serving an area with a high prevalence of socioeconomic deprivation. The population requiring admission had a median age of 76 years, included almost equal numbers of men and women, and commonly had comorbidities. … Read more
Evidence shows weak antiviral activity and no improvement in symptom outcomes. Study: Antiviral efficacy of fluoxetine in early symptomatic COVID-19: an open-label, randomised, controlled, adaptive platform trial (PLATCOV). Image Credit: luchschenF/Shutterstock.com In a recent study published in eClinicalMedicine, researchers characterized the antiviral activity of a selective serotonin reuptake inhibitor (SSRI), fluoxetine, in early coronavirus disease 2019 (COVID-19). … Read more